Antibody-mediated phagocytosis contributes to the anti-tumor activity of the therapeutic antibody daratumumab in lymphoma and multiple myeloma
Overdijk, Marije B, Verploegen, Sandra, Bögels, Marijn, van Egmond, Marjolein, van Bueren, Jeroen J Lammerts, Mutis, Tuna, Groen, Richard WJ, Breij, Esther, Martens, Anton CM, Bleeker, Wim K, Parren, Paul WHI
Published in mAbs (04.03.2015)
Published in mAbs (04.03.2015)
Get full text
Journal Article
Monoclonal antibodies targeting CD38 in hematological malignancies and beyond
van de Donk, Niels W. C. J., Janmaat, Maarten L., Mutis, Tuna, Lammerts van Bueren, Jeroen J., Ahmadi, Tahamtan, Sasser, A. Kate, Lokhorst, Henk M., Parren, Paul W. H. I.
Published in Immunological reviews (01.03.2016)
Published in Immunological reviews (01.03.2016)
Get full text
Journal Article
Human IgG2 Antibodies against Epidermal Growth Factor Receptor Effectively Trigger Antibody-Dependent Cellular Cytotoxicity but, in Contrast to IgG1, Only by Cells of Myeloid Lineage
Schneider-Merck, Tanja, Lammerts van Bueren, Jeroen J, Berger, Sven, Rossen, Kai, van Berkel, Patrick H.C, Derer, Stefanie, Beyer, Thomas, Lohse, Stefan, Bleeker, Wim K, Peipp, Matthias, Parren, Paul W. H. I, van de Winkel, Jan G. J, Valerius, Thomas, Dechant, Michael
Published in The Journal of immunology (1950) (01.01.2010)
Published in The Journal of immunology (1950) (01.01.2010)
Get full text
Journal Article
When blood transfusion medicine becomes complicated due to interference by monoclonal antibody therapy
Oostendorp, Marlies, Lammerts van Bueren, Jeroen J., Doshi, Parul, Khan, Imran, Ahmadi, Tahamtan, Parren, Paul W.H.I., van Solinge, Wouter W., De Vooght, Karen M.K.
Published in Transfusion (Philadelphia, Pa.) (01.06.2015)
Published in Transfusion (Philadelphia, Pa.) (01.06.2015)
Get full text
Journal Article
Pre-clinical evaluation of CD38 chimeric antigen receptor engineered T cells for the treatment of multiple myeloma
Drent, Esther, Groen, Richard W J, Noort, Willy A, Themeli, Maria, Lammerts van Bueren, Jeroen J, Parren, Paul W H I, Kuball, Jürgen, Sebestyen, Zsolt, Yuan, Huipin, de Bruijn, Joost, van de Donk, Niels W C J, Martens, Anton C M, Lokhorst, Henk M, Mutis, Tuna
Published in Haematologica (Roma) (01.05.2016)
Published in Haematologica (Roma) (01.05.2016)
Get full text
Journal Article
Antibody fucosylation differentially impacts cytotoxicity mediated by NK and PMN effector cells
Peipp, Matthias, Lammerts van Bueren, Jeroen J., Schneider-Merck, Tanja, Bleeker, Wim W.K., Dechant, Michael, Beyer, Thomas, Repp, Roland, van Berkel, Patrick H.C., Vink, Tom, van de Winkel, Jan G.J., Parren, Paul W.H.I., Valerius, Thomas
Published in Blood (15.09.2008)
Published in Blood (15.09.2008)
Get full text
Journal Article
Complement-Dependent Tumor Cell Lysis Triggered by Combinations of Epidermal Growth Factor Receptor Antibodies
DECHANT, Michael, WEISNER, Wencke, VALERIUS, Thomas, BERGER, Sven, PEIPP, Matthias, BEYER, Thomas, SCHNEIDER-MERCK, Tanja, LAMMERTS VAN BUEREN, Jeroen J, BLEEKER, Wim K, PARREN, Paul W. H. I, VAN DE WINKEL, Jan G. J
Published in Cancer research (Chicago, Ill.) (01.07.2008)
Published in Cancer research (Chicago, Ill.) (01.07.2008)
Get full text
Journal Article
The Therapeutic CD38 Monoclonal Antibody Daratumumab Induces Programmed Cell Death via Fcγ Receptor-Mediated Cross-Linking
Overdijk, Marije B, Jansen, J H Marco, Nederend, Maaike, Lammerts van Bueren, Jeroen J, Groen, Richard W J, Parren, Paul W H I, Leusen, Jeanette H W, Boross, Peter
Published in The Journal of immunology (1950) (01.08.2016)
Published in The Journal of immunology (1950) (01.08.2016)
Get full text
Journal Article
Systematic study of tissue factor expression in solid tumors
Bono, Johann S., Harris, Jeffrey R., Burm, Saskia M., Vanderstichele, Adriaan, Houtkamp, Mischa A., Aarass, Saida, Riisnaes, Ruth, Figueiredo, Ines, Nava Rodrigues, Daniel, Christova, Rossitza, Olbrecht, Siel, Niessen, Hans W. M., Ruuls, Sigrid R., Schuurhuis, Danita H., Lammerts van Bueren, Jeroen J., Breij, Esther C. W., Vergote, Ignace
Published in Cancer reports (01.02.2023)
Published in Cancer reports (01.02.2023)
Get full text
Journal Article
Effect of target dynamics on pharmacokinetics of a novel therapeutic antibody against the epidermal growth factor receptor : Implications for the mechanisms of action
LAMMERTS VAN BUEREN, Jeroen J, BLEEKER, Wim K, BOGH, Henrik O, HOUTKAMP, Mischa, SCHUURMAN, Janine, VAN DE WINKEL, Jan G. J, PARREN, Paul W. H. I
Published in Cancer research (Chicago, Ill.) (01.08.2006)
Published in Cancer research (Chicago, Ill.) (01.08.2006)
Get full text
Journal Article
antibody zalutumumab inhibits epidermal growth factor receptor signaling by limiting intra- and intermolecular flexibility
Lammerts van Bueren, Jeroen J, Bleeker, Wim K, Brännström, Annika, von Euler, Anne, Jansson, Magnus, Peipp, Matthias, Schneider-Merck, Tanja, Valerius, Thomas, van de Winkel, Jan G.J, Parren, Paul W.H.I
Published in Proceedings of the National Academy of Sciences - PNAS (22.04.2008)
Published in Proceedings of the National Academy of Sciences - PNAS (22.04.2008)
Get full text
Journal Article
Complement‐mediated tumor‐specific cell lysis by antibody combinations targeting epidermal growth factor receptor (EGFR) and its variant III (EGFRvIII)
Klausz, Katja, Berger, Sven, Lammerts van Bueren, Jeroen J., Derer, Stefanie, Lohse, Stefan, Dechant, Michael, van de Winkel, Jan G. J., Peipp, Matthias, Parren, Paul W. H. I., Valerius, Thomas
Published in Cancer science (01.10.2011)
Published in Cancer science (01.10.2011)
Get full text
Journal Article
Zenocutuzumab, a HER2xHER3 Bispecific Antibody, Is Effective Therapy for Tumors Driven by NRG1 Gene Rearrangements
Schram, Alison M, Odintsov, Igor, Espinosa-Cotton, Madelyn, Khodos, Inna, Sisso, Whitney J, Mattar, Marissa S, Lui, Allan J W, Vojnic, Morana, Shameem, Sara H, Chauhan, Thrusha, Torrisi, Jean, Ford, Jim, O'Connor, Marie N, Geuijen, Cecile A W, Schackmann, Ron C J, Lammerts van Bueren, Jeroen J, Wasserman, Ernesto, de Stanchina, Elisa, O'Reilly, Eileen M, Ladanyi, Marc, Drilon, Alexander, Somwar, Romel
Published in Cancer discovery (02.05.2022)
Published in Cancer discovery (02.05.2022)
Get full text
Journal Article
Oncogenic KRAS Impairs EGFR Antibodies' Efficiency by C/EBPβ-Dependent Suppression of EGFR Expression
Derer, Stefanie, Berger, Sven, Schlaeth, Martin, Schneider-Merck, Tanja, Klausz, Katja, Lohse, Stefan, Overdijk, Marije B, Dechant, Michael, Kellner, Christian, Nagelmeier, Iris, Scheel, Andreas H, Lammerts van Bueren, Jeroen J, van de Winkel, Jan G.J, Parren, Paul W.H.I, Peipp, Matthias, Valerius, Thomas
Published in Neoplasia (New York, N.Y.) (01.03.2012)
Published in Neoplasia (New York, N.Y.) (01.03.2012)
Get full text
Journal Article
Daratumumab-mediated lysis of primary multiple myeloma cells is enhanced in combination with the human anti-KIR antibody IPH2102 and lenalidomide
Nijhof, Inger S, Lammerts van Bueren, Jeroen J, van Kessel, Berris, Andre, Pascale, Morel, Yannis, Lokhorst, Henk M, van de Donk, Niels W C J, Parren, Paul W H I, Mutis, Tuna
Published in Haematologica (Roma) (01.02.2015)
Published in Haematologica (Roma) (01.02.2015)
Get full text
Journal Article
Anti-galactose-α-1,3-galactose IgE from allergic patients does not bind α-galactosylated glycans on intact therapeutic antibody Fc domains
Parren, Paul W H I, van Bueren, Jeroen J Lammerts, Rispens, Theo, Verploegen, Sandra, van der Palen-Merkus, Tjitske, Turinsky, Andrei L, Stapel, Steven, Workman, Lisa J, James, Hayley, van Berkel, Patrick H C, van de Winkel, Jan G J, Platts-Mills, Thomas A E
Published in Nature biotechnology (01.07.2011)
Published in Nature biotechnology (01.07.2011)
Get full text
Journal Article
Epidermal growth factor receptor (EGFR) antibody-induced antibody-dependent cellular cytotoxicity plays a prominent role in inhibiting tumorigenesis, even of tumor cells insensitive to EGFR signaling inhibition
Overdijk, Marije B, Verploegen, Sandra, van den Brakel, Jeroen H, Lammerts van Bueren, Jeroen J, Vink, Tom, van de Winkel, Jan G J, Parren, Paul W H I, Bleeker, Wim K
Published in The Journal of immunology (1950) (15.09.2011)
Published in The Journal of immunology (1950) (15.09.2011)
Get full text
Journal Article
Dual Mode of Action of a Human Anti-Epidermal Growth Factor Receptor Monoclonal Antibody for Cancer Therapy
Bleeker, Wim K, Lammerts van Bueren, Jeroen J, van Ojik, Heidi H, Gerritsen, Arnout F, Pluyter, Marielle, Houtkamp, Mischa, Halk, Ed, Goldstein, Joel, Schuurman, Janine, van Dijk, Marc A, van de Winkel, Jan G. J, Parren, Paul W. H. I
Published in The Journal of immunology (1950) (01.10.2004)
Published in The Journal of immunology (1950) (01.10.2004)
Get full text
Journal Article
Novel human antibody therapeutics: The age of the Umabs
Ruuls, Sigrid R., Lammerts van Bueren, Jeroen J., van de Winkel, Jan G. J., Parren, Paul W. H. I.
Published in Biotechnology journal (01.10.2008)
Published in Biotechnology journal (01.10.2008)
Get full text
Journal Article
Daratumumab displays in vitro and in vivo anti-tumor activity in models of B-cell non-Hodgkin lymphoma and improves responses to standard chemo-immunotherapy regimens
Vidal-Crespo, Anna, Matas-Céspedes, Alba, Rodriguez, Vanina, Rossi, Cédric, Valero, Juan G, Serrat, Neus, Sanjuan-Pla, Alejandra, Menéndez, Pablo, Roué, Gaël, López-Guillermo, Armando, Giné, Eva, Campo, Elías, Colomer, Dolors, Bezombes, Christine, van Bueren, Jeroen Lammerts, Chiu, Christopher, Doshi, Parul, Pérez-Galán, Patricia
Published in Haematologica (Roma) (01.04.2020)
Published in Haematologica (Roma) (01.04.2020)
Get full text
Journal Article